BankiewiczK. S.; BringasJ.; PivirottoP.; KutzscherE.; NagyD.; EmborgM. E.Technique for bilateral intracranial implantation of cells in monkeys using an automated delivery system.Cell Transplant.9: 595–607; 2000.
2.
BesJ. C.; TkaczukJ.; CzechK. A.; TafaniM.; BastideR.; CarateroC.; PappasG. D.; LazorthesY.One-year chromaffin cell allograft survival in cancer patients with chronic pain: Morphological and functional evidence.Cell Transplant.7: 227–238; 1998.
3.
CunninghamJ.; OiwaY.; NagyD.; PodsakoffG.; ColosiP.; BankiewiczK. S.Distribution of AAV-TK following intracranial convection-enhanced delivery into rats.Cell Transplant.9: 585–594; 2000.
4.
EatonM. J.; MartinezM.; KarmallyS.; LopezT.; SagenJ.Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain.Cell Transplant.9: 637–656; 2000.
5.
HaqueN. S. K.; IsacsonO.Neurotrophic factors NGF and FGF-2 alter levels of huntingtin (IT15) in striatal neuronal cell cultures.Cell Transplant.9: 623–627; 2000.
6.
HowellL. L.; ByrdL. D.; McDonoughA. M.; IuvoneP. M.; BakayR. A. E.Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation.Cell Transplant.9: 609–622; 2000.
7.
NakamuraK.; AhmedM.; BarrE.; LeidenJ. M.; KangU. J.The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.Cell Transplant.9: 567–576; 2000.
8.
PetersénÅ.; HanssonO.; EmgårdM.; BrundinP.Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.Cell Transplant.9: 577–584; 2000.